Ambev S A : Extract of the Minutes of the Meeting of the Board of Directors of Ambev S.A. held on April 25, 2023, drawn up in summary form - Form 6-K
April 26, 2023 at 11:07 am
Share
Extract of the Minutes of the Meeting of the Board of Directors of Ambev S.A.
held on April 25, 2023, drawn up in summary form
1.
Date, Time and Venue. On April 25, 2023, starting at 10:00 a.m., with the participation of the members, that ratified their votes by writing, as authorized by article 19, paragraph 1st, of the Company's bylaws.
2.
Call and Attendance. Call notice duly given pursuant to the Company's bylaws. Meeting with attendance of Mr. Victorio Carlos De Marchi and Mr. Michel Dimitrios Doukeris, copresidents, and Messrs. Milton Seligman, Roberto Moses Thompson Motta, Nelson José Jamel, Fernando Mommensohn Tennenbaum, Lia Machado de Matos, Fabio Colletti Barbosa, Antonio Carlos Augusto Ribeiro Bonchristiano, Marcos de Barros Lisboa and Claudia Quintella Woods.
3.
Board. Chairman: Victorio Carlos De Marchi; Secretary: Letícia Rudge Barbosa Kina.
4.
Resolutions. It was unanimously and unrestrictedly resolved by the Directors:
4.1. Option Plan and Capital Increase. In accordance with the procedure approved by the Board of Directors at a meeting held on March 25, 2019, regarding the issuance of new shares to be delivered to the beneficiaries of the programs under the Company's Stock Option Plan[1] that exercise their respective options, to verify the capital increase detailed in Exhibit I within the authorized capital limit as provided for in article 6 of the Company's bylaws and pursuant to article 166, item III, of Law 6,404/76, and to determine the Company's Board of Executive Officers to promote the registration of the capital increase with the competent Board of Trade, in compliance with the provisions of article 166, paragraph 1, of Law 6,404/76.
In view of the exercise of options between 03/30/2023 and 04/19/2023 (included), as detailed in Exhibit I, 3,616,433 new common shares were issued for the total issuance price of R$ 47,411,436.63, with the capital stock increasing from R$ 58,130,517,165.22 to R$ 58,177,928,601.85. The capital stock is now divided into 15,753,833,284 registered common shares, with no par value.
The new issued shares shall participate under equal conditions with the other shares of all the benefits and advantages that may be declared as of the date hereof.
5.
Closure. With no further matters to be discussed, these Minutes hereof were drawn up and duly executed.
São Paulo, April 25, 2023.
/s/ Victorio Carlos De Marchi
/s/ Michel Dimitrios Doukeris
/s/ Milton Seligman
/s/ Roberto Moses Thompson Motta
/s/ Nelson José Jamel
/s/ Fernando Mommensohn Tennenbaum
/s/ Lia Machado de Matos
/s/ Fabio Colletti Barbosa
/s/ Antonio Carlos Augusto Ribeiro Bonchristiano
/s/ Marcos de Barros Lisboa
/s/ Claudia Quintella Woods
/s/ Letícia Rudge Barbosa Kina
Secretary
[1] Stock Option Plan of the Company approved in the Extraordinary General Meeting of July 30, 2013
AmBev SA published this content on 26 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2023 10:06:06 UTC.
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labattâs operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV.
AMBEV S.A. 
